NCT00004392
- Conditions
- Apnea, Death, Death, Sudden, +14 more
- Locations
-
Not specified
Clinical trial condition
Infant Death
Explore clinical trials studying Infant Death. Study availability and eligibility vary by location and protocol.
54 public trials
10 recruiting studies
Infant Death trial results
Active, Not Recruiting
RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome)
NCT07236606
- Conditions
- Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +24 more
- Locations
-
- St. Peter's University Hospital New Brunswick, New Jersey, United States
Active, Not Recruiting
A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter Syndrome
NCT04251026
- Conditions
- Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +22 more
- Locations
-
- UCSF Benioff Children's Hospital Oakland, California, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
- UNC Children's Research Institute Chapel Hill, North Carolina, United States
- UPMC | Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)
NCT03566043
- Conditions
- Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +23 more
- Locations
-
- University of California San Francisco, Benioff Children's Hospital Oakland, California, United States
- St. Peter's University Hospital New Brunswick, New Jersey, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders Pittsburgh, Pennsylvania, United States